| Thursday, April 3, 2014 |
|
AATS-ASCVTS POSTGRADUATE COURSE
ADULT
NEW TECHNOLOGIES AND PROCEDURES IN ADULT CARDIAC SURGERY |
AATS-ASCVTS POSTGRADUATE COURSE
CONGENITAL
VALVE DISEASE IN CHILDREN |
AATS-ASCVTS POSTGRADUATE COURSE
THORACIC
NEW TECHNOLOGIES AND PROCEDURES IN LUNG CANCER |
|
| CORONARY DISEASE |
| Moderators: Joseph Sabik, USA & David Fullerton, USA |
| 08:30 - 08:50 |
Hybrid revascularization: Is this the new frontier? Michael Halkos, USA |
| 08:50 - 09:15 |
Left main stenting should be the standard of care.
Pro: İlke Sipahi, Turkey
Con: Joseph Sabik, USA |
| 09:15 - 09:30 |
Choice of conduits: Best in Practice. David Fullerton, USA |
| 09:30 - 09:45 |
Discussion |
|
| PULMONARY VALVE |
| Moderators: Carl Backer, USA & Sertaç Çiçek, Turkey |
| 08:30 - 08:50 |
Valve sparing and reconstructive techniques. Carl Backer, USA |
| 08:50 - 09:10 |
Pulmonary valve replacement: Timing and techniques. Winfield Wells, USA |
| 09:10 - 09:30 |
Right ventricular outflow tract reconstruction: Conduit options.
Sertaç Çiçek, Turkey |
| 09:30 - 09:45 |
Discussion |
|
| DIAGNOSIS AND STAGING |
| Moderators: Hasan Batırel,Turkey & Douglas E. Wood,USA |
| 08:30 - 08:50 |
Tobacco and Surgery. Nazmi Bilir, Turkey |
| 08:50 - 09:10 |
Screening for Lung Cancer (What has been done and is being done in different countries). Hasan Batırel, Turkey |
| 09:10 - 09:30 |
Current role of EBUS/EUS (EBUS/EUS versus Mediastinoscopy) John Tam, Singapore |
| 09:30 - 09:45 |
Discussion |
|
| COFFEE BREAK 09:45 - 10:15 |
| MITRAL VALVE THERAPIES |
| Moderators: W. Randolph Chitwood, USA & Tomislav Mihaljevic, UAE |
| 10.15 – 10.35 |
Management of ischemic mitral valve disease. W. Randolph Chitwood, USA |
| 10.35 – 11.00 |
All isolated MV surgery should be done minimally invasive
Pro: Theo Kofidis, Singapore
Con: Kenton Zehr, USA |
| 11.00 – 11.15 |
Transcatheter mitral valve therapies: from sternotomy to percutaneous approach-a paradigm shift? Jean-François Obadia, France |
| 11.15 – 11.35 |
Techniques in mitral valve repair: from Barlow’s to degenerative. Tomislav Mihaljevic, UAE |
| 11.35 – 11.50 |
Discussion |
|
| MITRAL VALVE |
| Moderators:Winfield Wells, USA & Shunji Sano, Japan |
| 10:15 - 10:35 |
Congenital mitral stenosis: Morphology and surgical approaches. Emre Belli, France |
| 10:35 - 10:55 |
Mitral regurgitation in children: Repair techniques.
Zohair Y. Al Halees, Saudi Arabia |
| 10:55 - 11:15 |
Rheumatic mitral disease in children: Is repair feasible?
Afksendyios Kalangos, Switzerland |
| 11:15 - 11:35 |
Reflections from adult repair techniques. Robert Dion, Belgium |
| 11:35 - 11:55 |
Discussion |
|
| SURGICAL CONTROVERSIES |
| Moderators: Ilgaz Dogusoy,Turkey & Joshua Sonett,USA |
| 10:15 - 10:35 |
VAMLA versus mediastinoscopy. Akif Turna, Turkey |
| 10:35 - 10:55 |
Open versus VATS resections in lung cancer. Joshua Sonett, USA |
| 10:55 - 11:15 |
Lobar versus sublobar resection in early stage lung cancer.
Ilgaz Doğusoy, Turkey |
| 11:15 - 11:35 |
Lymph node dissection (dissection versus sampling).
Alper Toker, Turkey |
| 11:35 - 11:50 |
Discussion |
|
| LUNCH BREAK 12:00 - 13:30 |
| AORTIC VALVE THERAPIES |
| Moderators: Vinod H. Thourani, USA & Vinayak Bapat, UK |
| 13.30 – 13.50 |
Minimalist transfemoral AVR: the new standard of care. Vinod H. Thourani, USA |
| 13.50 – 14.10 |
Techniques in non-transfemoral AVR. Vinayak Bapat, UK |
| 14.10 – 14.30 |
All patients with aortic stenosis regardless of their risk should have TAVR.
Pro: Alain Cribier, France
Con: Carlos-A Mestres, Spain
|
| 14.30 – 14.50 |
Sutureless AVR: benefits and technique. Michael Borger, Germany |
| 14.50 – 15.10 |
Discussion |
|
| AORTIC VALVE |
| Moderators: Christian Pizarro, USA & A. Sampath Kumar, India |
| 13:30 - 13:50 |
Aortic regurgitation in children: Repair techniques. Yves D'Udekem, Australia |
| 13:50 - 14:10 |
Critical aortic stenosis in neonates and infants. Shunji Sano, Japan |
| 14:10 - 14:30 |
Ross procedure: Ideal technique and candidate? John H. Calhoon, USA |
| 14:30 - 14:50 |
When all else fails: Options for valve replacement.
A. Sampath Kumar, India |
| 14:50 - 15:10 |
Discussion |
|
| SURGERY FOR LOCALLY ADVANCED NSCLC |
| Moderators: Kamil Kaynak,Turkey & Walter Weder,Switzerland |
| 13:30 - 13:50 |
Neoadjuvant therapy for NSCLC.
Yeşim Eralp, Turkey |
| 13:50 - 14:10 |
Restaging after Induction therapy in 3A – B Disease.
Cengiz Gebitekin, Turkey |
| 14:10 - 14:30 |
Pulmonary arterioplasty and vena cava reconstruction as part of lung cancer resection. Douglas E. Wood, USA |
| 14:30 - 14:50 |
En-Bloc vertebrectomy and lung resection for lung cancer.
Keith S. Naunheim, USA |
| 14:50 - 15:10 |
Discussion |
|
| COFFEE BREAK 15:10 - 15:30 |
| POTPOURRI |
| Moderators: Jose Pomar, Spain & Duke Cameron, USA |
| 15.30 – 15.50 |
Techniques in valve sparing root replacement. Duke Cameron, USA |
| 15.50 – 16.10 |
TEVAR and Hybrid Thoracic Stenting: Use in aneurysmal and Type B dissections. Toru Kuratani, Japan |
| 16.10 – 16.30 |
Hybrid atrial fibrillation surgery: Techniques and Outcomes, is this the best of both worlds? Gorav Ailawadi, USA |
| 16.30 – 16.50 |
Techniques in atrial fibrillation surgery. Jose Pomar, Spain |
| 16.50 – 17.00 |
Discussion |
|
| TRICUSPID VALVE |
Moderators: Afksendyios Kalangos, Switzerland &
John H. Calhoon, USA |
| 15:30 - 15:50 |
Tricuspid repair in Ebstein’s anomaly: Is there a superior technique?
Christian Pizarro, USA |
| 15:50 - 16:10 |
Congenital Non-Ebstein tricuspid regurgitation: Surgical techniques. Gilles Dreyfus, Monaco |
| 16:10 - 16:30 |
Atrioventricular valve repair in single ventricle. Victor Tsang, UK |
| 16:30 - 16:50 |
Individualizing surgical strategy for the Patient with Ebstein’s Malformation.
Qingyu Wu, China |
| 16:50 - 17:00 |
Discussion |
|
| MANAGING SMALL PERIPHERAL TUMORS |
| Moderators: Jun Nakajima,Japan & Keith Naunheim,USA |
| 15:30 - 15:50 |
Role of thoracoscopic segmentectomy for early stage lung carcinomas. Dominique Gossot,France |
| 15:50 - 16:10 |
Surgery for GGO. Jun Nakajima, Japan |
| 16:10 - 16:30 |
SBRT – for whom. Kayıhan Engin, Turkey |
| 16:30 - 16:50 |
The role of NCCN guidelines and the future of evidence based thoracic surgery. Robbin G. Cohen, USA |
| 16:50 - 17:00 |
Discussion |
|
| WELCOME RECEPTION (CONGRESS CENTER) 17:30 - 19:00 |
